A prospective study of frailty in nephrology-referred patients with CKD

Baback Roshanravan, Minesh Khatri, Cassianne Robinson-Cohen, Greg Levin, Kushang V. Patel, Ian H. De Boer, Stephen Seliger, John Ruzinski, Jonathan Himmelfarb, Bryan Kestenbaum

Research output: Contribution to journalArticle

131 Citations (Scopus)

Abstract

Background: Frailty is a construct developed to characterize a state of reduced functional capacity in older adults. However, there are limited data describing the prevalence or consequences of frailty in middle-aged patients with chronic kidney disease (CKD). Study Design: Observational study. Setting & Participants: 336 non-dialysis-dependent patients with stages 1-4 CKD with estimated glomerular filtration rate (eGFR) <90 mL/min/1.73 m2 (by the CKD-EPI [CKD Epidemiology Collaboration] serum creatinine-based equation) or evidence of microalbuminuria enrolled in the Seattle Kidney Study, a clinic-based cohort study. Findings were compared with community-dwelling older adults in the Cardiovascular Health Study. Outcome: Prevalence and determinants of frailty in addition to its association with the combined outcome of all-cause mortality or renal replacement therapy. Measurements: We defined frailty according to established criteria as 3 or more of the following characteristics: slow gait, weakness, unintentional weight loss, exhaustion, and low physical activity. We estimated kidney function using serum cystatin C concentrations (eGFRcys) to minimize confounding due to relationships of serum creatinine levels with muscle mass and frailty. Results: The mean age of the study population was 59 years and mean eGFRcys was 51 mL/min/1.73 m2. The prevalence of frailty (14.0%) was twice that of the much older non-CKD reference population (P < 0.01). The most common frailty components were physical inactivity and exhaustion. After adjustment including diabetes, eGFRcys categories of <30 and 30-44 mL/min/1.73 m2 were associated with a 2.8- (95% CI, 1.3-6.3) and 2.1 (95% CI, 1.0-4.7)-fold greater prevalence of frailty compared with GFR cys <60 mL/min/1.73 m2. There were 63 events during a median 987 days of follow-up. After adjustment, the frailty phenotype was associated with an estimated 2.5 (95% CI, 1.4-4.4)-fold greater risk of death or dialysis therapy. Limitations: Cross-sectional study design obscures inference regarding temporal relationships between CKD and frailty. Conclusions: Frailty is relatively common in middle-aged patients with CKD and is associated with lower eGFRcys and increased risk of death or dialysis therapy.

Original languageEnglish (US)
Pages (from-to)912-921
Number of pages10
JournalAmerican Journal of Kidney Diseases
Volume60
Issue number6
DOIs
StatePublished - Dec 1 2012
Externally publishedYes

Fingerprint

Nephrology
Chronic Renal Insufficiency
Prospective Studies
Dialysis
Creatinine
Serum
Independent Living
Kidney
Cystatin C
Renal Replacement Therapy
Kidney Diseases
Glomerular Filtration Rate
Gait
Population
Observational Studies
Weight Loss
Epidemiology
Cohort Studies
Cross-Sectional Studies
Exercise

Keywords

  • chronic kidney disease
  • Frailty
  • functional limitation
  • mortality

ASJC Scopus subject areas

  • Nephrology

Cite this

Roshanravan, B., Khatri, M., Robinson-Cohen, C., Levin, G., Patel, K. V., De Boer, I. H., ... Kestenbaum, B. (2012). A prospective study of frailty in nephrology-referred patients with CKD. American Journal of Kidney Diseases, 60(6), 912-921. https://doi.org/10.1053/j.ajkd.2012.05.017

A prospective study of frailty in nephrology-referred patients with CKD. / Roshanravan, Baback; Khatri, Minesh; Robinson-Cohen, Cassianne; Levin, Greg; Patel, Kushang V.; De Boer, Ian H.; Seliger, Stephen; Ruzinski, John; Himmelfarb, Jonathan; Kestenbaum, Bryan.

In: American Journal of Kidney Diseases, Vol. 60, No. 6, 01.12.2012, p. 912-921.

Research output: Contribution to journalArticle

Roshanravan, B, Khatri, M, Robinson-Cohen, C, Levin, G, Patel, KV, De Boer, IH, Seliger, S, Ruzinski, J, Himmelfarb, J & Kestenbaum, B 2012, 'A prospective study of frailty in nephrology-referred patients with CKD', American Journal of Kidney Diseases, vol. 60, no. 6, pp. 912-921. https://doi.org/10.1053/j.ajkd.2012.05.017
Roshanravan, Baback ; Khatri, Minesh ; Robinson-Cohen, Cassianne ; Levin, Greg ; Patel, Kushang V. ; De Boer, Ian H. ; Seliger, Stephen ; Ruzinski, John ; Himmelfarb, Jonathan ; Kestenbaum, Bryan. / A prospective study of frailty in nephrology-referred patients with CKD. In: American Journal of Kidney Diseases. 2012 ; Vol. 60, No. 6. pp. 912-921.
@article{2f90fe65064245a1aca30276f4e22038,
title = "A prospective study of frailty in nephrology-referred patients with CKD",
abstract = "Background: Frailty is a construct developed to characterize a state of reduced functional capacity in older adults. However, there are limited data describing the prevalence or consequences of frailty in middle-aged patients with chronic kidney disease (CKD). Study Design: Observational study. Setting & Participants: 336 non-dialysis-dependent patients with stages 1-4 CKD with estimated glomerular filtration rate (eGFR) <90 mL/min/1.73 m2 (by the CKD-EPI [CKD Epidemiology Collaboration] serum creatinine-based equation) or evidence of microalbuminuria enrolled in the Seattle Kidney Study, a clinic-based cohort study. Findings were compared with community-dwelling older adults in the Cardiovascular Health Study. Outcome: Prevalence and determinants of frailty in addition to its association with the combined outcome of all-cause mortality or renal replacement therapy. Measurements: We defined frailty according to established criteria as 3 or more of the following characteristics: slow gait, weakness, unintentional weight loss, exhaustion, and low physical activity. We estimated kidney function using serum cystatin C concentrations (eGFRcys) to minimize confounding due to relationships of serum creatinine levels with muscle mass and frailty. Results: The mean age of the study population was 59 years and mean eGFRcys was 51 mL/min/1.73 m2. The prevalence of frailty (14.0{\%}) was twice that of the much older non-CKD reference population (P < 0.01). The most common frailty components were physical inactivity and exhaustion. After adjustment including diabetes, eGFRcys categories of <30 and 30-44 mL/min/1.73 m2 were associated with a 2.8- (95{\%} CI, 1.3-6.3) and 2.1 (95{\%} CI, 1.0-4.7)-fold greater prevalence of frailty compared with GFR cys <60 mL/min/1.73 m2. There were 63 events during a median 987 days of follow-up. After adjustment, the frailty phenotype was associated with an estimated 2.5 (95{\%} CI, 1.4-4.4)-fold greater risk of death or dialysis therapy. Limitations: Cross-sectional study design obscures inference regarding temporal relationships between CKD and frailty. Conclusions: Frailty is relatively common in middle-aged patients with CKD and is associated with lower eGFRcys and increased risk of death or dialysis therapy.",
keywords = "chronic kidney disease, Frailty, functional limitation, mortality",
author = "Baback Roshanravan and Minesh Khatri and Cassianne Robinson-Cohen and Greg Levin and Patel, {Kushang V.} and {De Boer}, {Ian H.} and Stephen Seliger and John Ruzinski and Jonathan Himmelfarb and Bryan Kestenbaum",
year = "2012",
month = "12",
day = "1",
doi = "10.1053/j.ajkd.2012.05.017",
language = "English (US)",
volume = "60",
pages = "912--921",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - A prospective study of frailty in nephrology-referred patients with CKD

AU - Roshanravan, Baback

AU - Khatri, Minesh

AU - Robinson-Cohen, Cassianne

AU - Levin, Greg

AU - Patel, Kushang V.

AU - De Boer, Ian H.

AU - Seliger, Stephen

AU - Ruzinski, John

AU - Himmelfarb, Jonathan

AU - Kestenbaum, Bryan

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Background: Frailty is a construct developed to characterize a state of reduced functional capacity in older adults. However, there are limited data describing the prevalence or consequences of frailty in middle-aged patients with chronic kidney disease (CKD). Study Design: Observational study. Setting & Participants: 336 non-dialysis-dependent patients with stages 1-4 CKD with estimated glomerular filtration rate (eGFR) <90 mL/min/1.73 m2 (by the CKD-EPI [CKD Epidemiology Collaboration] serum creatinine-based equation) or evidence of microalbuminuria enrolled in the Seattle Kidney Study, a clinic-based cohort study. Findings were compared with community-dwelling older adults in the Cardiovascular Health Study. Outcome: Prevalence and determinants of frailty in addition to its association with the combined outcome of all-cause mortality or renal replacement therapy. Measurements: We defined frailty according to established criteria as 3 or more of the following characteristics: slow gait, weakness, unintentional weight loss, exhaustion, and low physical activity. We estimated kidney function using serum cystatin C concentrations (eGFRcys) to minimize confounding due to relationships of serum creatinine levels with muscle mass and frailty. Results: The mean age of the study population was 59 years and mean eGFRcys was 51 mL/min/1.73 m2. The prevalence of frailty (14.0%) was twice that of the much older non-CKD reference population (P < 0.01). The most common frailty components were physical inactivity and exhaustion. After adjustment including diabetes, eGFRcys categories of <30 and 30-44 mL/min/1.73 m2 were associated with a 2.8- (95% CI, 1.3-6.3) and 2.1 (95% CI, 1.0-4.7)-fold greater prevalence of frailty compared with GFR cys <60 mL/min/1.73 m2. There were 63 events during a median 987 days of follow-up. After adjustment, the frailty phenotype was associated with an estimated 2.5 (95% CI, 1.4-4.4)-fold greater risk of death or dialysis therapy. Limitations: Cross-sectional study design obscures inference regarding temporal relationships between CKD and frailty. Conclusions: Frailty is relatively common in middle-aged patients with CKD and is associated with lower eGFRcys and increased risk of death or dialysis therapy.

AB - Background: Frailty is a construct developed to characterize a state of reduced functional capacity in older adults. However, there are limited data describing the prevalence or consequences of frailty in middle-aged patients with chronic kidney disease (CKD). Study Design: Observational study. Setting & Participants: 336 non-dialysis-dependent patients with stages 1-4 CKD with estimated glomerular filtration rate (eGFR) <90 mL/min/1.73 m2 (by the CKD-EPI [CKD Epidemiology Collaboration] serum creatinine-based equation) or evidence of microalbuminuria enrolled in the Seattle Kidney Study, a clinic-based cohort study. Findings were compared with community-dwelling older adults in the Cardiovascular Health Study. Outcome: Prevalence and determinants of frailty in addition to its association with the combined outcome of all-cause mortality or renal replacement therapy. Measurements: We defined frailty according to established criteria as 3 or more of the following characteristics: slow gait, weakness, unintentional weight loss, exhaustion, and low physical activity. We estimated kidney function using serum cystatin C concentrations (eGFRcys) to minimize confounding due to relationships of serum creatinine levels with muscle mass and frailty. Results: The mean age of the study population was 59 years and mean eGFRcys was 51 mL/min/1.73 m2. The prevalence of frailty (14.0%) was twice that of the much older non-CKD reference population (P < 0.01). The most common frailty components were physical inactivity and exhaustion. After adjustment including diabetes, eGFRcys categories of <30 and 30-44 mL/min/1.73 m2 were associated with a 2.8- (95% CI, 1.3-6.3) and 2.1 (95% CI, 1.0-4.7)-fold greater prevalence of frailty compared with GFR cys <60 mL/min/1.73 m2. There were 63 events during a median 987 days of follow-up. After adjustment, the frailty phenotype was associated with an estimated 2.5 (95% CI, 1.4-4.4)-fold greater risk of death or dialysis therapy. Limitations: Cross-sectional study design obscures inference regarding temporal relationships between CKD and frailty. Conclusions: Frailty is relatively common in middle-aged patients with CKD and is associated with lower eGFRcys and increased risk of death or dialysis therapy.

KW - chronic kidney disease

KW - Frailty

KW - functional limitation

KW - mortality

UR - http://www.scopus.com/inward/record.url?scp=84868712372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868712372&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2012.05.017

DO - 10.1053/j.ajkd.2012.05.017

M3 - Article

C2 - 22770927

AN - SCOPUS:84868712372

VL - 60

SP - 912

EP - 921

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 6

ER -